Xiang Zuo-Lin相关文献与解析，生知库 | 链接生命科学的每一步

Brown adipose tissue and tumor presence: a retrospective association analysis considering the role of body mass index

棕色脂肪组织与肿瘤存在：一项考虑体重指数作用的回顾性关联分析

期刊:Lipids in Health and Disease

影响因子:4.2

doi:10.1186/s12944-025-02825-x

Liu, Lin-Lin; Ren, Jing-Ming; Yang, Yi-Hong; Zhao, Jun; Xiang, Zuo-Lin

A meta-contrastive learning approach for clinical drug-drug interaction extraction from biomedical literature

一种基于元对比学习的生物医学文献临床药物相互作用提取方法

期刊:PLoS Computational Biology

影响因子:3.6

doi:10.1371/journal.pcbi.1013722

Jia, Yaxun; Yuan, Zhu; Zhu, Lian; Xiang, Zuo-Lin

发表日期：2025

文献求助收藏

The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome

原发肿瘤切除术对肝转移患者的价值：10 年随访结果

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-024-16386-3

Liu, Lin-Lin; Lin, Yu-Kun; Xiang, Zuo-Lin

Radiotherapy volume delineation based on MRI and (18)F-FDG-PET/MRI in locally recurrent rectal cancer

基于MRI和(18)F-FDG-PET/MRI的局部复发性直肠癌放射治疗靶区勾画

期刊:Abdominal Radiology

影响因子:2.2

doi:10.1007/s00261-025-04859-2

Lin, Yu-Kun; Zhu, Lei-Lei; Zhao, Jun; Xiang, Zuo-Lin

Circ-0044539 promotes lymph node metastasis of hepatocellular carcinoma through exosomal-miR-29a-3p

Circ-0044539 通过外泌体 miR-29a-3p 促进肝细胞癌淋巴结转移

期刊:Cell Death & Disease

影响因子:9.6

doi:10.1038/s41419-024-07004-x

Yang, Yi; Chen, Xue-Qin; Jia, Ya-Xun; Ma, Jie; Xu, Di; Xiang, Zuo-Lin

Correction: Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma

更正：对KLF2作为晚期肝细胞癌纤维化和免疫浸润相关预后生物标志物的综合分析

期刊:BMC Bioinformatics

影响因子:3.3

doi:10.1186/s12859-023-05623-3

Chen, Xue-Qin; Ma, Jie; Xu, Di; Xiang, Zuo-Lin

Biomedical relation extraction method based on ensemble learning and attention mechanism

基于集成学习和注意力机制的生物医学关系抽取方法

期刊:BMC Bioinformatics

影响因子:3.3

doi:10.1186/s12859-024-05951-y

Jia, Yaxun; Wang, Haoyang; Yuan, Zhu; Zhu, Lian; Xiang, Zuo-Lin

发表日期：2024

文献求助收藏

Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma

对KLF2作为晚期肝细胞癌纤维化和免疫浸润相关预后生物标志物的综合分析

期刊:BMC Bioinformatics

影响因子:3.3

doi:10.1186/s12859-023-05391-0

Chen, Xue-Qin; Ma, Jie; Xu, Di; Xiang, Zuo-Lin

Corrigendum: Establishment and validation of prognostic nomograms for patients with parotid gland adenocarcinoma not otherwise specified: a SEER analysis from 2004 to 2016

更正：建立和验证腮腺腺癌（未另行说明）患者预后列线图：2004年至2016年SEER分析

期刊:Frontiers in Surgery

影响因子:1.8

doi:10.3389/fsurg.2023.1341579

Wang, Zi-Meng; Xiang, Zuo-Lin

HMGB1 orchestrates tumor-osteoclast crosstalk to drive bone metastasis in hepatocellular carcinoma

HMGB1 调控肿瘤细胞与破骨细胞之间的相互作用，从而促进肝细胞癌的骨转移。

Brown adipose tissue and tumor presence: a retrospective association analysis considering the role of body mass index

棕色脂肪组织与肿瘤存在：一项考虑体重指数作用的回顾性关联分析

A meta-contrastive learning approach for clinical drug-drug interaction extraction from biomedical literature

一种基于元对比学习的生物医学文献临床药物相互作用提取方法

The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome

原发肿瘤切除术对肝转移患者的价值：10 年随访结果

Radiotherapy volume delineation based on MRI and (18)F-FDG-PET/MRI in locally recurrent rectal cancer

基于MRI和(18)F-FDG-PET/MRI的局部复发性直肠癌放射治疗靶区勾画

Circ-0044539 promotes lymph node metastasis of hepatocellular carcinoma through exosomal-miR-29a-3p

Circ-0044539 通过外泌体 miR-29a-3p 促进肝细胞癌淋巴结转移

Correction: Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma

更正：对KLF2作为晚期肝细胞癌纤维化和免疫浸润相关预后生物标志物的综合分析

Biomedical relation extraction method based on ensemble learning and attention mechanism

基于集成学习和注意力机制的生物医学关系抽取方法

Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma

对KLF2作为晚期肝细胞癌纤维化和免疫浸润相关预后生物标志物的综合分析

Corrigendum: Establishment and validation of prognostic nomograms for patients with parotid gland adenocarcinoma not otherwise specified: a SEER analysis from 2004 to 2016

更正：建立和验证腮腺腺癌（未另行说明）患者预后列线图：2004年至2016年SEER分析